Presenilins as therapeutic targets for the treatment of Alzheimer's disease.

Overview
Identity
Additional Document Info
View All

authors

Todd Golde, MD, PhD
Younkin, S G

publication date

January 2001

published in

Trends in molecular medicine Journal

has subject area